As of Today, Whole Health JC Offers 19 IV Drips and Counting

JEFFERSON CITY, Mo. - August 5, 2022 - (Newswire.com)

For years, Whole Health JC has used integrative medicine to help their patients take back control of their health and wellness. One of the clinic's key treatments is IV Therapy, which reintroduces and balances vitamins, minerals, and antioxidants in the body.

IV Therapy allows for nutrients to work faster and more efficiently. Today, Whole Health JC is recognized as Central Missouri's only physician-administered and monitored Ketamine IV clinic located in Jefferson City, MO, near Columbia, MO. Along with this prestigious title, the clinic also offers 19+ different IV drips, including: 

• Immune Booster IV
• Ketamine IV
• Migraine Relief IV
• Pain Relief IV
• Stress & Anxiety IV
• Weight Loss IV

The goal of IV Therapy is to relieve aches, pains, and inconsistencies that are caused by vitamin deficiencies. They are also used by patients who need an extra boost of vitamins in their system, such as hard-working athletes or those who suffer from medical issues such as thyroid disorders.

Since IVs can speed up the absorption of essential minerals and vitamins, it is an extremely beneficial process for patients who struggle to take in enough vitamins from their diet alone. Through these revitalizing therapies, patients will replenish their internal supply of nutrients and revitalize their health.

For questions or to schedule a free consultation, you can call Dr. Jen at 573-893-5500. 

Press Release Service by Newswire.com

Original Source: Whole Health JC Offers Revitalizing IV Therapy in Jefferson City & Columbia, Missouri

Clinically proven allograft material comes prepackaged in a syringe, giving dentists a convenient and reliable means of grafting sites for bone regeneration.

IRVINE, Calif. - August 5, 2022 - (Newswire.com)

Glidewell's Newport Surgical^™ line of bone grafting solutions was created to provide dentists with a simplified assortment of bone grafting materials and instruments for the full range of indications performed in the general practice, from socket regeneration to full periodontal reconstruction. Now, the company is introducing a new addition to the collection: RAPTOS^® Cortico-Cancellous Blend in a Syringe specially designed to make the delivery of allograft for extraction sockets, bony defects, immediate implant sites and other clinical applications simpler and more convenient.

Traditionally, dentists in need of bone grafting material have had to order the allograft on its own, hydrate it, and then apply it manually with an instrument or load it into a syringe after hydration. With RAPTOS Cortico-Cancellous Blend in a Syringe, clinicians have an all-in-one tool for grafting sites with predictable and cost-effective results. 

Each syringe contains prepackaged mineralized cortico-cancellous allograft and is ready to use after a quick and simple hydration procedure. Users will simply remove the outside cap and gently tap the device to loosen the particles sufficiently before aspirating a saline solution or the patient's blood into the syringe. The 0.25 cc and 0.5 cc (priced at $42 and $65, respectively) are packaged for single use. The largest size (1.0 cc priced at $92) comes packaged as two syringes.

"Bone grafting after tooth extraction or in preparation for implant placement has become everyday dentistry for most general practitioners," says Dr. Neil Park, vice president of clinical affairs at Glidewell. "RAPTOS Cortico-Cancellous Blend in a Syringe makes these procedures even more efficient at a remarkably good price."

The allograft blend combines the optimal features of cortical and cancellous bone. Cortical bone provides the space maintenance that allows the time for bone regeneration to occur, while cancellous bone allows for better cell migration and faster remodeling. The finely ground size of the mineralized allograft's particles fosters rapid site revascularization and increased structural integrity with a resorption rate of four to six months.

Glidewell ensures that RAPTOS Cortico-Cancellous Blend in a Syringe, like other products in the Newport Surgical line, originates from a single, convenient supplier and is FDA-cleared and naturally sourced. By doing so, the longstanding implant solutions provider aims to deliver a product with quality that dentists know they can trust. This product will play a key role in furthering Glidewell's philosophy to simplify and improve every aspect of treatment, from implant placement to delivery of the final restoration.

This product addition strengthens Newport Surgical's comprehensive line of bone grafting solutions, which includes essential tools like sutures, wound dressing, collagen membranes and the Newport Surgical Implant and Bone Grafting Instrument Kit. This simple yet comprehensive line of high-quality products gives clinicians everything they need to perform most implant-related procedures in their dental practices.

For the RAPTOS Cortico-Cancellous Blend in a Syringe, along with the full array of Newport Surgical materials and instruments, visit glidewell.com/newportsurgical or call 888-303-3975. To learn more about Glidewell's comprehensive implant and restorative solutions, visit glidewell.com/implant-solutions or call 800-839-9755.

RAPTOS is a registered trademark of Citagenix Inc.

MEDIA CONTACT:

Eldon Thompson, Sr. Director of Marketing
Glidewell
[email protected]

Press Release Service by Newswire.com

Original Source: Glidewell Adds RAPTOS® Cortico-Cancellous Blend in a Syringe to Newport Surgical™ Line of Bone Grafting Solutions

This service is available in real time upon request with a 30-minute notice 24/7/365.

SANTA CLARA, Calif. - August 3, 2022 - (Newswire.com)

Zeto, Inc., announced today that it now offers remote routine or continuous electroencephalography (EEG) monitoring services to its customers. At a fixed hourly rate, an accredited monitoring service provides real-time remote video EEG monitoring by registered EEG technologists (R.EEG.T) when such personnel are unavailable on-site. This service is available in real time upon request with a 30-minute notice 24/7/365, at no extra charge during nights, weekends, or holidays. 

Driven by the shortage of in-house monitoring capability, this additional service has become increasingly relevant to hospitals and clinics alike to meet the need for timely, high-quality patient care. Zeto is committed to opening its EEG cloud platform for such services as remote work by medical personnel is gaining adoption.

How it works: When Zeto customers need EEG specialists, they simply click on a service request button in the Zeto software, which notifies the monitoring service immediately, and monitoring starts within 30 minutes. By choice, this service can be requested in advance. In real time, an R.EEG.T remotely views the EEG and patient video, making annotations and notifying care providers when needed.

At an affordable hourly flat rate, providers now have the choice to use this simple and quick remote service. Alternatively, providers can use the Zeto Cloud to have their own EEG technologists monitor and annotate from afar. These options are crucial steps that ensure patient needs can be met with minimal delay while complying with standard practices and documentation requirements.

"We believe this service will be beneficial for everyone, including hospitals that would not be limited by the shortage of EEG professionals and can take care of their patients as fast as needed. Patients can have an EEG recorded, monitored, and reviewed for escalation of critical findings within minutes after the doctor orders it, and registered EEG technologists across the U.S. can apply their skills, even if they are not on-site 24/7/365," said Florian Strelzyk, Chief Sales Officer at Zeto.

In May, Zeto began offering a remote EEG physician reading service to its customers. This was made possible through a partnership with a physician-led organization dedicated to providing expert, high-quality telemedicine-assisted EEG interpretation to hospitals and outpatient settings, regardless of geographic location.

About Zeto

Zeto, Inc. is an award-winning, privately held medical technology company located in Santa Clara, California, that is focused on transforming the way electroencephalography (EEG) is performed at hospitals and clinics. Zeto's revolutionary FDA-cleared EEG headset and cloud platform bring the traditional EEG procedure to the 21st century.

To learn more about Zeto's products, including the remote EEG monitoring, please visit: https://zeto-inc.com/ or email us at [email protected].

Press Release Service by Newswire.com

Original Source: Zeto Now Offers Remote Routine and Continuous EEG Monitoring Service to Its Customers for an Hourly Flat Rate

New York, NY-based oral-health tech investment fund Revere Partners announces investment in FeatherPay to accelerate the consumerization of the patient payment experience in key healthcare segments.

NEW YORK - August 3, 2022 - (Newswire.com)

Revere Partners, the first independent venture fund providing capital for cutting-edge innovations in the oral and systemic health sectors, today announced an investment in FeatherPay, an Atlanta, GA-based healthcare fintech startup. Revere Partners will provide capital, oral-health and related industry expertise, and a vast network of prospective customers and partnerships to support FeatherPay's mission to be healthcare's best payment experience.

"It's unnecessarily difficult for patients to pay healthcare bills, and changing consumer behavior dynamics are compounding the problem of practices getting paid for services. The opportunity to communicate with and accept payments from patients anywhere and on any device is massive. FeatherPay's technology is an elegant, world-class solution to a complex problem across healthcare segments. We are excited to support the mission and vision of these exceptional founders and their incredible team," said Jeremy Krell, MBA, DMD and Managing Director of Revere Partners.

"We are thrilled to welcome Revere Partners to the team. The addition of such a credible and influential force in oral health is both validation of our opportunity and jet fuel for our vision. We are excited to partner with Jeremy and the broader team at Revere Partners in aggressive pursuit of our mission," said Craig Haynor, CEO and co-founder of FeatherPay.

To learn more about FeatherPay and schedule a 15-minute demo, visit www.featherpay.io.

Revere Partners is on a mission to change the landscape of dental and systemic health ventures—to bring market awareness, business acumen, and the top minds in the field together to elevate innovations and optimize both patient and provider experience. A diverse mix of 75 renowned professionals comprises the Revere team—recruited across key areas of dentistry, including DSOs, insurers, manufacturers, distributors, professional associations, academics, labs, retailers and more.  

Press contact [email protected]

FeatherPay is a payment platform that drives revenue and profits, while lowering operational costs for practices, all while delivering a great experience for patients. FeatherPay brings all the different ways a practice enables their patients to pay into a single experience for patients and staff. Patients receive clear simple statements via text, email or paper statement, and can combine multiple payment methods in a single transaction, whether paying in the office, remotely on a mobile device, or even by phone.  FeatherPay also automates and simplifies and digitizes back office operations such as patient billing and AR collections, reconciliation, auditing, refunds, and more, leading to efficient and accurate processes that save time and money.

Press contact [email protected]

Press Release Service by Newswire.com

Original Source: Revere Partners Announces Investment in FeatherPay

Mindpeak breast cancer algorithms have been seamlessly integrated into the gold-standard image management software, CaloPix 5, enhancing the pathologist's possibilities.

PARIS - August 3, 2022 - (Newswire.com)

Tribun Health, the European leader in software development for digital pathology, is pleased to announce a strategic partnership with Mindpeak, a global leader for pathology AI software with world-class industry experts in the development of artificial intelligence algorithms to provide precision and speed in clinical pathology.

Together, Tribun Health and Mindpeak help pathologists analyze whole-slide-images (WSI) of immunohistochemically (IHC) stained human breast cancer tissue (biomarkers: Ki-67, ER and PR) to detect, classify, count cancer cells and to provide the respective quantitative score. This way, pathologists are relieved of tedious and repetitive tasks, which allows them to focus on the most complex cases where their expertise matters most. Tribun Health's Image Management System and Mindpeak's AI software are both CE-IVD marked, allowing their use as a medical device for clinical diagnostics and in research alike. 

"As a provider of AI algorithms, we integrate our AI tools deeply into the leading pathology workflow platforms (IMS) available in order to provide the best user experience for pathologists and thereby a reproducible, accurate and quick diagnosis for the patients and their families. For this reason, we are very pleased to announce the integration of our  breast cancer algorithms into CaloPix 5 by Tribun Health", says Felix Faber, CEO and Founder at Mindpeak.

It is also an alliance between two European companies looking to improve the way diagnosis is delivered by democratizing pathology with AI. "I am very excited about this strategic partnership. We are combining our fields of expertise to deliver ultimate clinical confidence and increased productivity. The integration and development of our catalog of the best third-party algorithms is an integral part of our end-to-end digital pathology suite, providing pathologists with a complete workflow for a high-value experience", says Jean-François Pomerol, CEO at Tribun Health. Mindpeak's algorithms are now available in the IMS CaloPix 5, ranked as Europe's top-performing digital pathology provider in 2022 by Klas Research, which is currently being deployed in various hospitals. Additional algorithms from Mindpeak, notably HER2 and PD-L1, will be integrated in a continuous mode.

About Mindpeak: Mindpeak, founded by Felix Faber and Dr. Tobias Lang, has been developing image analysis software for pathologists based on artificial intelligence since 2018. Partnering with several international laboratories and leading pathology service providers, Mindpeak is continuously expanding its product range and developing it into an indispensable component of the digitalised pathology workflow. Mindpeak's  AI algorithms for breast cancer diagnosis were the first AI tools for digital pathology to make it into clinical routine in the USA. 

Contact: Carsten Maltzan; PR Advisor; carsten.maltzan(@)mindpeak.ai

About Tribun Health: Tribun Health is a Paris-based company, addressing a significant and fast-growing need for end-to-end pathology department digitization. The privately held company is a pioneer in pathology workflow solutions and is considered the industry leader by winning the Best in Klas 2022 award for the most successful digital pathology provider in Europe. Tribun Health's extensive, decade-long expertise drives confidence for laboratories looking for a seamless transition to a digital pathology platform.

Contact: Lorine Marcoux; Marketing Manager; lmarcoux(@)tribun.health

Press Release Service by Newswire.com

Original Source: Tribun Health Enters a Strategic Partnership With Mindpeak to Provide Pathologists With the Most Advanced AI Diagnostic Tool for Breast Cancer

4 Beauty Aesthetics Institute for Plastic Surgery

MIAMI - August 2, 2022 - (Newswire.com)

Constantino Mendieta MD, 4 Beauty Aesthetic Institute for Plastic Surgery has been awarded #1 on Newsweek's list of America's Best Plastic Surgeons 2022. This prestigious award is presented by Newsweek and Statista Inc., the world-leading statistics portal and industry ranking provider. The awards list was announced on June 15, 2022 and can currently be viewed on Newsweek's website.

Best Plastic Surgeons - Liposuction (newsweek.com)

America's Best Plastic Surgeons 2022 recognizes the best plastic surgeons in the U.S. concentrating on four major procedures: Breast Augmentation, Liposuction, Eyelid Surgery, Facelift, and Rhinoplasty. Statista invited over 2,000 medical experts (doctors/surgeons, plastic surgery clinic managers & health care professionals) to participate in an online survey. The rankings feature the top 150 plastic surgeons for Breast Augmentation, Liposuction, Facelift, and Rhinoplasty. 100 plastic surgeons were awarded for eyelid surgery. Our complex methodology ensures the quality and validity of the ranking. The evaluation process was comprised of two steps:

In-State and Out-of-State recommendations: an independent national survey which resulted in more than 5,900 recommendations from doctors/surgeons, plastic surgery clinic managers & health care professionals with knowledge of plastic surgery.

Quality Score: Additionally, participants were asked to rank the quality dimensions which influence the quality of plastic surgeons. Participants were asked to differentiate between these variables:

• Quality of care 

• Continuity of care

• Quality of technical equipment

Certification: Plastic Surgeons receive a 5% bonus on their score if they have a American Board of Plastic Surgery (ABPS) certification

Constantino Mendieta MD, 4 Beauty Aesthetic Institute for Plastic Surgery is ecstatic to be recognized on Newsweek's list of America's Best Plastic Surgeons 2022.

Constantino Mendieta MD, 4 Beauty Aesthetic Institute for Plastic Surgery can be contacted via email, phone, website and Instagram.

Website: https://www.buttsbymendieta.com

Instagram: @doctormendieta

CONTACT INFORMATION:

4 Beauty Aesthetic Institute for Plastic Surgery 
Dr. Constantino Mendieta
(305) 860-0717
[email protected]

Press Release Service by Newswire.com

Original Source: Dr. Constantino Mendieta Awarded #1 on Newsweek's America's Best Plastic Surgeons 2022 List